id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-286638-bqxyb61p	Singh, Awadhesh Kumar	Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations	2020-04-09		.txt	text/plain	4824	281	46	The disease burden of coronavirus infectious disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) has been increasing continuously with more than a million confirmed patients and more than 45 thousand deaths globally [1] . Emerging data suggests that COVID-19 is common in patients with diabetes, hypertension, and cardiovascular disease (CVD), although the prevalence rate varied in different studies as well in country-wise data. Evolving data also suggest that patients of COVID-19 with diabetes are more often associated with severe or critical disease varying from 14 to 32% in different studies [15e18, 20, 22, 24] . Though there is limited data about the association of blood glucose levels with disease course in COVID-19 at present, data from other infections like SARS and influenza H1N1 has shown that patients with poor glycemic control have increased risk of complications and death [60, 61] .	./cache/cord-286638-bqxyb61p.txt	./txt/cord-286638-bqxyb61p.txt